Dohj LLC Grows Position in Danaher Co. (NYSE:DHR)

Dohj LLC raised its holdings in Danaher Co. (NYSE:DHR) by 105.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,345 shares of the conglomerate’s stock after purchasing an additional 1,715 shares during the quarter. Dohj LLC’s holdings in Danaher were worth $835,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of DHR. Acadian Asset Management LLC raised its holdings in shares of Danaher by 7.6% in the 3rd quarter. Acadian Asset Management LLC now owns 7,915 shares of the conglomerate’s stock valued at $1,962,000 after acquiring an additional 558 shares in the last quarter. O Shaughnessy Asset Management LLC raised its holdings in shares of Danaher by 55.3% during the 3rd quarter. O Shaughnessy Asset Management LLC now owns 30,928 shares of the conglomerate’s stock valued at $7,673,000 after buying an additional 11,019 shares in the last quarter. Mather Group LLC. raised its holdings in shares of Danaher by 98.1% during the 3rd quarter. Mather Group LLC. now owns 3,175 shares of the conglomerate’s stock valued at $788,000 after buying an additional 1,572 shares in the last quarter. Bamco Inc. NY raised its holdings in shares of Danaher by 30.3% during the 3rd quarter. Bamco Inc. NY now owns 21,743 shares of the conglomerate’s stock valued at $5,394,000 after buying an additional 5,060 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Danaher by 328.0% during the 3rd quarter. Tower Research Capital LLC TRC now owns 25,076 shares of the conglomerate’s stock valued at $6,221,000 after buying an additional 19,217 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In other Danaher news, CEO Rainer Blair sold 47,175 shares of Danaher stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the completion of the transaction, the chief executive officer now owns 115,995 shares in the company, valued at $28,908,273.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Danaher news, CEO Rainer Blair sold 47,175 shares of Danaher stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the completion of the transaction, the chief executive officer now owns 115,995 shares in the company, valued at $28,908,273.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Alan G. Spoon sold 708 shares of the business’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total value of $172,454.64. Following the completion of the transaction, the director now owns 116,202 shares of the company’s stock, valued at approximately $28,304,483.16. The disclosure for this sale can be found here. Insiders have sold 148,783 shares of company stock worth $37,536,717 over the last ninety days. 11.10% of the stock is owned by corporate insiders.

Danaher Trading Up 0.1 %

Shares of DHR stock traded up $0.18 during trading hours on Friday, reaching $251.94. The company’s stock had a trading volume of 990,305 shares, compared to its average volume of 2,820,554. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31. Danaher Co. has a one year low of $182.09 and a one year high of $269.11. The stock has a market capitalization of $186.61 billion, a P/E ratio of 42.68, a P/E/G ratio of 3.88 and a beta of 0.85. The firm’s fifty day simple moving average is $255.36 and its 200 day simple moving average is $246.19.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same period in the previous year, the company posted $2.36 earnings per share. The firm’s revenue was down 2.6% on a year-over-year basis. Equities research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 0.43%. Danaher’s dividend payout ratio is presently 18.31%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Tuesday. Robert W. Baird raised their price objective on Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a report on Wednesday, April 24th. Citigroup lifted their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. HSBC raised Danaher from a “hold” rating to a “buy” rating and lifted their price target for the stock from $250.00 to $280.00 in a research note on Wednesday, April 17th. Finally, Barclays lifted their price target on Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 24th. Six investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $269.29.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.